About Us > Awards, prizes

Awards and Prizes


Innovation Prizes

In the course of our R&D work we strive to develop such generic products that can help to provide a more cost-effective therapy for a wider range of patient groups. It is an outstanding recognition for us when our researchers’ work is awarded by an innovation prize.

Innovation Prize (2014) – bisoprolol-amlodipine tablet


The 2014 Industrial Innovation Prize was awarded to our bisoprolol-amlodipine fixed-dose combination product.

The novelty and uniqueness of the antihypertensive developed by the company derives from the successful realization of significant multiple objectives during the development process. The blood pressure lowering effects of bisoprolol and amlodipine complete each other beneficially due to the combination of the two active ingredients with different mechanisms of action. Furthermore, the new antihypertensive – together with the appropriate dosage form – provides not only a high added value product with high purity and stability, but enables patients to take only one tablet instead of two.

Innovation Prize (2013) – ramipril-amlodipine capsule

The 2013 Innovation Prize of the Hungarian Intellectual Property Office was won by our fixed-dose combination drug. This antihypertensive, developed by Egis is considered unique in the pharmaceutical market, combining two active ingredients (ramipril and amlodipine) in one capsule that are taken separately in two different tablets. Fixed-dose combination therapies significantly increase patient compliance, which has been confirmed by international studies as well. According to these, more than 30% of the patients end the therapy if they have to take the drugs separately, whereas this rate is only 12% in the case of fixed-dose combination therapies. Patient compliance has major significance for public health as the efficient control of blood pressure can decrease the mortality risk of stroke by 45% and of heart attack by 24%.

Innovation Grand Prize (2011) - clopidogrel

Our anticoagulant clopidogrel product was awarded the 2011 Innovation Grand Prize. We developed a novel manufacturing process (patented in 2008) for the production of racemic clopidogrel – the key intermediate of clopidogrel hydrogen sulfate –, which enabled the launch of our product before the expiry of the original product’s patents. We also developed a manufacturing process to produce the drug substance with appropriate morphology, which was granted Hungarian and European patents in 2009. Our pharmaceutical innovation resulted in a composition that ensures the high stability of the product and an environment-friendly manufacturing technology, protected by Hungarian and European patents from 2004 and 2006 respectively.

Innovation Prize (2008) - quetiapine

In 2008 the Industrial Innovation Prize was granted to our second-generation antipsychotic drug containing quetiapine hemifumarate. The drug substance is protected by Hungarian and European patents. The chemical innovation resulted in a product containing an excellent-quality active ingredient and a significantly more cost-effective production. As a result of this pharmaceutical (formulation) innovation, by means of the optimized composition, Egis can produce tablets of 20-50 percent less weight depending on their dose strengths.

Innovation Prize (2007) - venlafaxine

The 2007 Innovation Prize of the Hungarian Chamber of Commerce and Industry was awarded to Egis’ anti-depressant retard capsule containing venlafaxine. The active substance of this anti-depressant drug is produced by a patented procedure, which significantly improves the purity of the product, makes manufacturing more cost-efficient, and has a more favorable environmental impact. As a result of the pharmaceutical development, the product is manufactured by a patented robust procedure and it is especially pure in light of the strict impurity limits set by authorities.

Innovation Prize (2006) - risperidone

The Hungarian Patent Office's Innovation Prize for 2006 was awarded to Egis’ atypical antipsychotic containing risperidone. The film tablets contain significantly less impurity than those found in the originator’s drug, typically one-third to half of those amounts.

Innovation Prize (2004) - sertraline

The Hungarian Patent Office's Innovation Prize for 2004 was won by Egis’ anti-depressant tablet containing sertraline. With the launch of this product, Egis made a significant contribution to ensure that a greater number of patients have access to a modern, reliable anti-depressant medicine.

Innovation Prize (2003) - carvedilol

The 2003 Innovation Prize of the Ministry of Economy and Transport was awarded to Egis' tablet containing carvedilol. The novel production process elaborated during the development of the beta blocker’s active ingredient is more economical and significantly more effective than the published process of the originator (71% compared to 43%), and results in an active ingredient that is freer of impurities and has consistently high quality.

Innovation Prize (1992) - nifedipine

The Hungarian Innovation Foundation awarded its 1992 Innovation Prize to Egis for its product line containing nifedipine. With this first-generation, antihypertensive calcium-antagonist, Egis managed to provide an alternative to the original product that until then enjoyed market monopoly in Hungary.


Further prizes and awards


Special prize at the Greennovation Grand Prize (2014)


Our company was awarded a special prize at the 3rd Greennovation Grand Prize in the category of Greennovative Manufacturer.



Budapest Brand (2013)

The municipality of Budapest awarded Egis the Budapest Brand in recognition of its long-standing contibution to the employment of the city’s residents and its economic results.


Excellent Hungarian Pharmaceutical Company (2013)
Egis was the first to receive this award of excellence for its outstanding achievement in Hungarian healthcare.

The best cafeteria system of the year (2010, 2011, 2013, 2015)

Having won in 2010, 2011 and 2013, Egis received a prize in the contest in 2015 again. “The best cafeteria system of the year” award recognizes those employers who provide fringe benefits in accordance with the regulations, run their cafeteria system in an optimal way and lay special emphasis on personal contact with their employees.


Special packaging prize for our Jovital C tablets (2010)
At the 27th Hungaropack Hungarian Packaging Design Contest the packaging design of our Jovital C chewing tablet product family was awarded by the Hungarian Association of Packaging and Materials Handling.

MagyarBrands (2010, 2011, 2012, 2013, 2014, 2015)

The MagyarBrands Award (the meaning of the word “magyar” is Hungarian) was by the jury of the Superbrands program to classify, present and acknowledge the best Hungarian brands.


Biker-friendly Workplace (2009, 2010, 2011)

In the competition announced within the framework of the “Biker Hungary” program, the appropriate bike infrastructure and the employees’ motivation for cycling were considered as advantages.


Superbrands (2008, 2009, 2010, 2011, 2012, 2013, 2014)

The juries consisting of Hungary’s most prestigious brand specialists select every year the financial and consumer brands out of thousands of leading brands. Egis has been one of the Superbrands in 7 consecutive years.


Progress Research Survey (2005, 2006, 2008, 2009, 2010, 2014)
In surveys conducted in 2005, 2006, 2008, 2009, 2010 and 2014 doctors considered Egis to be the pharmaceutical company of the year and the most prestigious, respected and ethical company among the producers of cardiovascular drugs.

Tódor Kármán Prize (2004)
Egis was awarded the Tódor Kármán Prize in 2004, primarily in recognition of its outstanding financial support provided to the Chemical Engineering Faculty of the Budapest University of Technology and Economics, and for its cooperation in education and research.

Special packaging prize for Vitamin C tablets (2004)
At the Hungaropack 2004 Hungarian packaging competition, Egis was awarded the special prize of the National Office for Research and Technology for the packaging of its 30-tablet box of 500 mg Vitamin C film tablets.


Drug of the Year Prize (1998)



In 1998, Egis' potassium substitute was voted Drug of the Year.